Clocking the conduction velocity of the visual pathway with optically pumped magnetometers
This project aims to develop a new diagnostic method using optically pumped magnetometers to measure high-frequency retinocortical conduction time for early detection of neurodegeneration.
Projectdetails
Introduction
The human visual pathway carries high volumes of information from the retina to distant regions of the visual cortex. The speed of this information transfer, retinocortical conduction time, has been proposed as a diagnostic measure of neurodegeneration.
Background
This conduction time has typically been estimated based on relatively slow evoked responses. However, we now know that high-frequency activity in both the retina and visual cortex precedes slower evoked responses by several tens of milliseconds.
Timing Differences
In addition, the difference in timing between the onset of high-frequency activity in the retina and cortex is more in line with the expected conduction velocities of the heavily myelinated visual pathway.
Project Proposal
This project proposes to develop and validate a new sensor technology, optically pumped magnetometers (OPMs), to measure this high-frequency retinocortical conduction time. The goal is to establish a diagnostic suitable for patients in the neurology and eye clinics to assess disease progression.
Expected Impacts
Impacts to myelination, circulation, and neural connectivity are all expected to reduce the conduction speed of the visual pathway, even before visual symptoms become apparent.
Advantages of the Proposed Technique
The proposed high-frequency conduction time technique should provide a more accurate and sensitive measure to detect these impacts, with high potential for translation into a clinical diagnostic method.
Measurement Procedure
We will furthermore streamline the measurement procedure to increase the comfort, duration, and feasibility for potential patient groups.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 30-6-2025 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- AARHUS UNIVERSITETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Optical imaging platform for high-throughput longitudinal studies of the eye in disease modelsThe OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use. | ERC Proof of... | € 150.000 | 2023 | Details |
Non-invasive Conduction Velocity Mapping in Brain Networks: A novel imaging framework for axonal fingerprinting of brain connections in health and diseaseThe CoM-BraiN project aims to non-invasively map axon diameters and conduction velocities in the brain using advanced MRI techniques to identify structural-function relationships in neurodegenerative disorders. | ERC Consolid... | € 1.999.994 | 2022 | Details |
Simulation-enhanced High-density Magnetomyographic Quantum Sensor Systems for Decoding Neuromuscular Control During MotionThis project aims to develop high-density Magnetomyography using quantum sensors to decode neuromuscular control, enabling breakthroughs in diagnostics and treatment of neurodegenerative diseases. | ERC Advanced... | € 3.499.763 | 2022 | Details |
Signal-enhanced MRI contrast agents for neurodegenerationThis project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents. | ERC Proof of... | € 150.000 | 2022 | Details |
Non-invasive patterned electrical neurostimulation of the retinaThis project aims to develop non-invasive trans-orbital stimulation techniques and bi-directional interfaces for retinal neurostimulation to enhance artificial vision in patients with retinal degenerative diseases. | ERC Advanced... | € 2.500.000 | 2023 | Details |
Optical imaging platform for high-throughput longitudinal studies of the eye in disease models
The OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use.
Non-invasive Conduction Velocity Mapping in Brain Networks: A novel imaging framework for axonal fingerprinting of brain connections in health and disease
The CoM-BraiN project aims to non-invasively map axon diameters and conduction velocities in the brain using advanced MRI techniques to identify structural-function relationships in neurodegenerative disorders.
Simulation-enhanced High-density Magnetomyographic Quantum Sensor Systems for Decoding Neuromuscular Control During Motion
This project aims to develop high-density Magnetomyography using quantum sensors to decode neuromuscular control, enabling breakthroughs in diagnostics and treatment of neurodegenerative diseases.
Signal-enhanced MRI contrast agents for neurodegeneration
This project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents.
Non-invasive patterned electrical neurostimulation of the retina
This project aims to develop non-invasive trans-orbital stimulation techniques and bi-directional interfaces for retinal neurostimulation to enhance artificial vision in patients with retinal degenerative diseases.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Optically-pumped magnetometer arrays for magnetoencephalographyOPMMEG aims to develop a cost-effective, scalable optically pumped magnetometer array for enhanced magnetoencephalography, improving epilepsy and TBI diagnosis across Europe. | EIC Transition | € 2.483.327 | 2022 | Details |
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGYOPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability. | EIC Pathfinder | € 3.276.577 | 2025 | Details |
Fast gated superconducting nanowire camera for multi-functional optical tomographThis project aims to develop a multifunctional optical tomograph using an innovative light sensor to enhance deep body imaging and monitor organ functionality with 100x improved signal-to-noise ratio. | EIC Pathfinder | € 2.495.508 | 2023 | Details |
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
High-dimensional electrical stimulation for visual prosthesisThe project aims to enhance visual prostheses by developing sophisticated stimulation protocols for existing microelectrodes, achieving a 20X improvement in spatial resolution to restore vision in blind patients. | EIC Pathfinder | € 2.105.228 | 2022 | Details |
Optically-pumped magnetometer arrays for magnetoencephalography
OPMMEG aims to develop a cost-effective, scalable optically pumped magnetometer array for enhanced magnetoencephalography, improving epilepsy and TBI diagnosis across Europe.
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY
OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.
Fast gated superconducting nanowire camera for multi-functional optical tomograph
This project aims to develop a multifunctional optical tomograph using an innovative light sensor to enhance deep body imaging and monitor organ functionality with 100x improved signal-to-noise ratio.
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.
High-dimensional electrical stimulation for visual prosthesis
The project aims to enhance visual prostheses by developing sophisticated stimulation protocols for existing microelectrodes, achieving a 20X improvement in spatial resolution to restore vision in blind patients.